Add BrightSurf on Google Email

Gene-tweaked albino toads go hungry

Albino cane toads created using CRISPR technology reveal that albinism affects survival and hunting abilities, with poor eyesight being the core problem. In controlled environments, albino tadpoles were less likely to survive and developed faster when competing with pigmented siblings for food and space.

SourceMacquarie University·JournalProceedings of the Royal Society B Biological Sciences·TypeExperimental study·DateAug 27, 2025

What causes spontaneous eye movements in albinism?

A new study from the Netherlands Institute for Neuroscience reveals that pendular nystagmus, a spontaneous back-and-forth movement of the eye, is caused by an abnormality in the nucleus of the optic tract. This condition hinders social eye contact and affects vision, with treatment methods often having unpleasant side effects.

SourceNetherlands Institute for Neuroscience - KNAW·JournalInvestigative Ophthalmology & Visual Science·DateAug 8, 2023

Baby white wallaby harboring hopping DNA

Researchers at Kyoto University have identified a genetic mutation causing albinism in wallabies, tracing it to an inserted retrovirus gene. The study found that the mutation was caused by a copy of the HIV-like virus inserted into the host's genome.

SourceKyoto University·JournalGenome·TypeExperimental study·DateMar 10, 2022

Pale melanomas masked by albino gene

Researchers found people with pale-colored melanomas are more likely to have an albinism gene mutation, which prevents brown pigment synthesis and increases skin cancer risk. This discovery could lead to personalized medicine and earlier treatment for patients with one mutated albinism gene.

SourceUniversity of Queensland·JournalPLOS ONE·DateSep 24, 2020

A treatment for one form of albinism?

Researchers have found that treating mice with OCA-1B, a form of oculocutaneous albinism, with nitisinone improves eye and skin pigmentation. The study suggests that nitisinone could potentially ameliorate vision loss in patients with OCA-1B.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 26, 2011